Jazz Pharmaceuticals valuation

JAZZ · NASDAQ · USD

Compare Jazz Pharmaceuticals
$240.71Change from previous close: +0.39%Absolute change: +$0.94

Close · November 17, 2026

Valuation

The P/E ratio is 71.5. The average price target of 22 analysts is $297.59.

Data as of November 15, 2026

Jazz Pharmaceuticals compared with similar companies

Jazz Pharmaceuticals's P/E (trailing 12 months): 71.5, +87% against the median of a group of 7 similar companies (38.3).

Jazz Pharmaceuticals's metrics compared with similar companies
MetricJazz PharmaceuticalsMedian25th–75th percentileBand
P/E (trailing 12 months)71.538.319.1 – 69.1High
Forward P/E9.0415.59.15 – 25.0Low
EV/EBITDA9.1017.013.4 – 27.9Low
Price/book3.697.544.09 – 14.6Low
Price/sales3.297.234.95 – 9.17Low
Gross margin91.1%77.3%71.2% – 91.5%Middle
Operating margin27.4%19.5%-5.3% – 29.2%Middle
Net margin4.4%4.4%-5.7% – 30.2%Middle
ROE5.1%8.3%-4.2% – 88.3%Middle
Debt/equity1.350.300.06 – 0.75High

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Jazz Pharmaceuticals: valuation over time

Jazz Pharmaceuticals P/E and dividend yield at each fiscal year end, 2016 to 2025.

Jazz Pharmaceuticals P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/E
2025$170.00-$5.84—
2024$123.15$8.6514.2
2023$123.00$6.1020.2
2022$159.31-$3.58—
2021$127.40-$5.52—
2020$165.05$4.2239.1
2019$149.28$9.0916.4
2018$123.96$7.3017.0
2017$134.65$7.9616.9
2016$109.03$6.4117.0

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only). Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$15.5B
Enterprise value
$18.29B
PEG
0.96
EV/revenue
3.88

Profitability and growth

ROA
6.9%
ROIC
8.2%
Revenue growth (year over year)
10.4%
Earnings growth (year over year)
-123.7%

Financial health

Total cash
$2.86B
Total debt
$5.65B
Current ratio
1.82
Quick ratio
1.47
Altman Z-Score
1.96
Piotroski F-Score
6.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
$297.59
Median price target
$300.00
High price target
$330.00
Low price target
$220.00
Analysts with a price target
22
Consensus
Strong buy
Forward EPS
$26.71
EPS estimate, current year
$14.95

Shares and trading

Beta
0.37
Average volume
879.09K
Shares outstanding
64.19M
Float
62.25M
Institutional ownership
106.1%
Insider ownership
3.4%
Short interest (% of float)
9.3%
Short ratio (days)
7.02